Lifeline Biotechnologies, Inc. (LLBO)

USD 0.0

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2022 2021 2020 2019 2018 2017
Revenue - - - - - 350 Thousand
Cost of Revenue - - - - - 630.00
Gross Profit - - - - - 349.37 Thousand
Operating Expenses - - - - 43.38 Thousand 107.45 Thousand
Selling, General and Administrative Expenses - - - - 43.38 Thousand 107.45 Thousand
Research and Development Expenses - - - - - -
Other Expenses - - - - - -
Cost and Expenses - - - - 43.38 Thousand 108.08 Thousand
Operating Income - - - - -43.39 Thousand 241.91 Thousand
Interest Expense - - - - - -
Income Tax Expense - - - - -161.14 Thousand -
Earnings before Tax - - - - -43.38 Thousand 241.91 Thousand
Net Income - - - - -43.38 Thousand 241.91 Thousand
Earnings Per Share Basic - - - - - 0.00
Earnings Per Share Diluted - - - - - 0.00
Weighted Average Shares Outstanding - - - - 3.13 Billion 3.13 Billion
Weighted Average Shares Outstanding (Diluted) - - - - 3.13 Billion 3.13 Billion
Gross Margin - - - - - 1.00
EBIT Margin - - - - - 0.69
Profit Margin - - - - - 0.69
EBITDA - - - - -43.39 Thousand 242.54 Thousand
Earnings Before Tax Margin - - - - - 0.69

Income Statement Charts